John F. DeCoteau

2.1k total citations
63 papers, 1.5k citations indexed

About

John F. DeCoteau is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, John F. DeCoteau has authored 63 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 21 papers in Pathology and Forensic Medicine and 16 papers in Hematology. Recurrent topics in John F. DeCoteau's work include Lymphoma Diagnosis and Treatment (13 papers), Chronic Myeloid Leukemia Treatments (11 papers) and Chronic Lymphocytic Leukemia Research (10 papers). John F. DeCoteau is often cited by papers focused on Lymphoma Diagnosis and Treatment (13 papers), Chronic Myeloid Leukemia Treatments (11 papers) and Chronic Lymphocytic Leukemia Research (10 papers). John F. DeCoteau collaborates with scholars based in Canada, United States and Japan. John F. DeCoteau's co-authors include C. Ronald Geyer, Marshall E. Kadin, Stuart A. Scott, Ryo Ichinohasama, Ashakumary Lakshmikuttyamma, Yu Luo, Robert Lowsky, Petra Knaus, Harvey F. Lodish and David P. Sheridan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and SHILAP Revista de lepidopterología.

In The Last Decade

John F. DeCoteau

59 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John F. DeCoteau Canada 24 903 401 372 168 139 63 1.5k
Masayuki Shiseki Japan 21 960 1.1× 439 1.1× 257 0.7× 116 0.7× 161 1.2× 53 1.6k
Jeong Hee Cho‐Vega United States 18 512 0.6× 581 1.4× 476 1.3× 170 1.0× 63 0.5× 44 1.4k
Sonia Minuzzo Italy 21 824 0.9× 397 1.0× 159 0.4× 210 1.3× 132 0.9× 49 1.5k
İlyas Şahin United States 19 516 0.6× 339 0.8× 269 0.7× 148 0.9× 41 0.3× 70 1.3k
Sylvie Giuriato France 21 1.3k 1.4× 388 1.0× 247 0.7× 450 2.7× 140 1.0× 35 2.2k
Weili Zhao China 21 485 0.5× 336 0.8× 379 1.0× 127 0.8× 39 0.3× 73 1.2k
Zheng Ge China 27 1.5k 1.7× 346 0.9× 114 0.3× 450 2.7× 131 0.9× 134 2.4k
Stefanie Löffek Germany 17 503 0.6× 371 0.9× 134 0.4× 70 0.4× 84 0.6× 24 1.4k
Harry W. Findley United States 23 1.1k 1.2× 634 1.6× 115 0.3× 237 1.4× 121 0.9× 54 1.8k

Countries citing papers authored by John F. DeCoteau

Since Specialization
Citations

This map shows the geographic impact of John F. DeCoteau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John F. DeCoteau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John F. DeCoteau more than expected).

Fields of papers citing papers by John F. DeCoteau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John F. DeCoteau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John F. DeCoteau. The network helps show where John F. DeCoteau may publish in the future.

Co-authorship network of co-authors of John F. DeCoteau

This figure shows the co-authorship network connecting the top 25 collaborators of John F. DeCoteau. A scholar is included among the top collaborators of John F. DeCoteau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John F. DeCoteau. John F. DeCoteau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bernhard, Wendy, et al.. (2026). Antibody‐Targeted Artificial T Cell and Natural Killer Cell Derived Vesicles for Cancer Immunotherapy. Journal of Extracellular Vesicles. 15(2). e70231–e70231.
2.
Pastushok, Landon, Shrutii Sarda, Wayne Hill, et al.. (2024). A Novel Single-Tube Next Generation Sequencing Assay for B-Cell Receptor Clonality Testing. SHILAP Revista de lepidopterología. 5(1). 45–65.
3.
Bernhard, Wendy, et al.. (2024). Antibody-targeted T cells and natural killer cells for cancer immunotherapy. Journal of Nanobiotechnology. 22(1). 640–640. 1 indexed citations
4.
Stockley, Tracy, Bernard Lo, John F. DeCoteau, et al.. (2023). Consensus Recommendations to Optimize the Detection and Reporting of NTRK Gene Fusions by RNA-Based Next-Generation Sequencing. Current Oncology. 30(4). 3989–3997. 3 indexed citations
5.
Park, Paul C., Kyle C. Kurek, John F. DeCoteau, et al.. (2022). CAP-ACP Workload Model for Advanced Diagnostics in Precision Medicine. American Journal of Clinical Pathology. 158(1). 105–111. 2 indexed citations
6.
Bernhard, Wendy, Kris Barreto, Ayman El‐Sayed, et al.. (2021). Pre-clinical study of IRDye800CW-nimotuzumab formulation, stability, pharmacokinetics, and safety. BMC Cancer. 21(1). 270–270. 12 indexed citations
7.
Pastushok, Landon, Leo S. Lin, Yu Luo, et al.. (2019). A Novel Cell-Penetrating Antibody Fragment Inhibits the DNA Repair Protein RAD51. Scientific Reports. 9(1). 11227–11227. 15 indexed citations
8.
9.
Freywald, Tanya, et al.. (2010). The EphB6 Receptor Cooperates with c-Cbl to Regulate the Behavior of Breast Cancer Cells. Cancer Research. 70(3). 1141–1153. 72 indexed citations
10.
Barreto, Kris, et al.. (2009). A Genetic Screen for Isolating “Lariat” Peptide Inhibitors of Protein Function. Chemistry & Biology. 16(11). 1148–1157. 16 indexed citations
11.
Zhao, Ronghua, John F. DeCoteau, C. Ronald Geyer, et al.. (2009). Loss of imprinting of the insulin-like growth factor II (IGF2) gene in esophageal normal and adenocarcinoma tissues. Carcinogenesis. 30(12). 2117–2122. 35 indexed citations
12.
Lakshmikuttyamma, Ashakumary, Stuart A. Scott, John F. DeCoteau, & C. Ronald Geyer. (2009). Reexpression of epigenetically silenced AML tumor suppressor genes by SUV39H1 inhibition. Oncogene. 29(4). 576–588. 89 indexed citations
13.
Suzuki, Naomi, Kengo Takeuchi, Shigeo Nakamura, et al.. (2008). Cytogenetic abnormality 46,XX,add(21)(q11.2) in a patient with follicular dendritic cell sarcoma. Cancer Genetics and Cytogenetics. 186(1). 54–57. 7 indexed citations
14.
Takahashi, Naoto, Élodie Pastural, Robert Lowsky, et al.. (2006). RIZ1 Is Downregulated during CML Progression and Displays Tumor Suppressor Properties in CML Cell Lines.. Blood. 108(11). 2134–2134. 2 indexed citations
15.
Torlakovic, Emina, Ana Slipicevic, Chris Robinson, et al.. (2006). Pax-5 Expression in Nonhematopoietic Tissues. American Journal of Clinical Pathology. 126(5). 798–804. 44 indexed citations
16.
17.
18.
Al‐Tweigeri, Taher, Anthony M. Magliocco, & John F. DeCoteau. (1999). Cortical Blindness as a Manifestation of Hypomagnesemia Secondary to Cisplatin Therapy: Case Report and Review of Literature. Gynecologic Oncology. 72(1). 120–122. 26 indexed citations
19.
Ichinohasama, Ryo, Ikuo Miura, Nao Kobayashi, et al.. (1998). Herpes Virus Type 8-Negative Primary Effusion Lymphoma Associated With PAX-5 Gene Rearrangement and Hepatitis C Virus. The American Journal of Surgical Pathology. 22(12). 1528–1537. 67 indexed citations
20.
Heng, Henry H., Robert Lowsky, Yi Xu, et al.. (1997). Cloning, Expression, and Chromosomal Localization to 11p12-13 of a Human LIM/HOMEOBOX Gene, hLim-1. DNA and Cell Biology. 16(6). 671–678. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masayuki Shiseki Breakdown of academic impact, for papers by Jeong Hee Cho‐Vega Breakdown of academic impact, for papers by Sonia Minuzzo Breakdown of academic impact, for papers by İlyas Şahin Breakdown of academic impact, for papers by Sylvie Giuriato Breakdown of academic impact, for papers by Weili Zhao Breakdown of academic impact, for papers by Zheng Ge Breakdown of academic impact, for papers by Stefanie Löffek Breakdown of academic impact, for papers by Harry W. Findley
Rankless by CCL
2026